New Molecular Mechanisms in the Development of Brain Tumors and Metastases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 28 February 2025
Special Issue Editors
Interests: noncoding RNAs; micro-RNAs; prostate cancer; nanotechnological delivery of anticancer drugs and nucleic acids; diagnostic markers in cancer; Urotensin II receptor; next-generation sequencing; predictive markers of response; circulating tumor cells
Special Issues, Collections and Topics in MDPI journals
Interests: Cancer Biology; treatment; tumors; oncology; Neurology; cancer therapy; chemotherapy; Neuro-Oncology; Glioblastoma
Special Issues, Collections and Topics in MDPI journals
Interests: oncology; biochemistry; nanotechnologies; RNA interference
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Brain tumors and metastases are among the most lethal neoplasms. Enhanced understanding of the molecular biology of both primary and secondary central nervous system tumors has led to changes in their clinical approach. However, despite these advances, patients with brain tumors have a poor prognosis.
The aim of this Special Issue is to draw attention to the state of the art of scientific research in the study of brain tumors. Particular emphasis will be placed on the most common primary brain tumor of adult age: glioblastoma. Importantly, knowledge about the molecular changes and heterogeneity of glioblastoma together with advances in the understanding of the cellular and molecular characteristics of its physiological barriers (above all the blood–brain barrier) represent new challenges in the treatment of glioblastoma patients. Contributions that examine the genetic and epigenetic landscape of glioblastoma, which may provide insights into its known heterogeneity and resilience, are welcome to be submitted. Knowledge of the tumor microenvironment, the blood–brain barrier, and new gene mutations could help to achieve this objective. Particular emphasis will also be placed on non-coding RNAs (i.e., microRNAs and long non-coding RNAs) in the definition of the growth, spreading, and chemo-radio and immunological resistance of brain tumors. The goal of this Special Issue is to discuss new research opportunities that can lead to precise and personalized medicine for these tumors, with a clear improvement in both the quality of life and survival of patients.
Prof. Dr. Michele Caraglia
Dr. Raffaele Addeo
Dr. Marianna Abate
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain tumor
- brain metastasis
- blood–brain barrier
- target therapy
- cancer molecular biology
- brain tumor microenvironment
- molecular biomarkers
